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INTRODUCTION
Most tumors in lower female genital area are originated
from vaginal or urethral mucosa (1, 2). Mostly, they are accom-
panied by apparent symptoms, such as vaginal bleeding or
hematuria, which lead to an easy detection of the tumor (2).
However, the mass developed at urethrovaginal septum with-
out definite involvement of mucosa of urethra or vagina is
rare and it does not show any obvious symptoms or signs
except urinary retention (3).
We report a case of endometrioid adenocarcinoma at ure-
throvaginal septum. The difficulty in diagnosis of the tumor
at urethrovaginal septum is discussed. 
CASE REPORT
A 61-yr-old woman presented with recurrent urinary tract
infection. She had been treated with antibiotics for urinary
tract infection several times. She had a history of smoking 1
pack per day for 20 yr, drinking 10 cups of coffee per day for
30 yr. Exposure to diethylstilbestrol during her fetal period
was uncertain. She had been receiving hormone replacement
treatment with estrogen and progesterone for past 5 yr in a
local clinic to alleviate menopausal symptoms including senile
vaginitis. The uterus was mobile and non-tender. And the
symphysis pubis had been felt as prominent. The mass was
enlarged to the size of walnut 4 month later. A pinpoint sized
ulceration at lower 1/3 of anterior vaginal wall elevation was
noticed after rotating vaginal speculum about 90
o to show
the anterior vaginal wall. Punch biopsy was performed and
the microscopy of the mass revealed endometrioid adenocar-
cinoma. A magnetic resonance imaging revealed 4.3×4.2
cm sized mass between urethra and vagina (Fig. 1). A positron
emission tomography-computed tomography revealed a focal
hypermetabolism at the site of mass.
All the results of complete blood count and blood chem-
istry were within normal limits with exception of urine anal-
ysis showing white blood cell and red blood cell count high-
er than 100/HPF. All serum tumor markers such as CA 125,
CA 72-4, CA 15-3, CA 19-9, TA-4, carcino embryonic anti-
gen, and neuron specific endolase were within normal lim-
its. A Pap smear result was normal and no high-risk human
papilloma virus was detected.
Anterior pelvic exenteration, bilateral salpingooophorec-
tomy, pelvic lymph node dissection, and urostomy with ileal
conduit were performed. An operative finding revealed a
walnut sized, soft, well-demarcated mass at urethrovaginal
septum. The uterus, both adnexae, and pelvic lymph nodes
had normal gross findings. There was no residual disease in
the abdomen and pelvis cavity at the completion of the oper-
ation. The postoperative course was uneventful except for
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Endometrioid Adenocarcinoma in Urethrovaginal Septum: 
A Diagnostic Pitfall
Primary endometrioid adenocarcinoma developed at urethrovaginal septum has
not been reported. A 61-yr-old woman presented with recurrent urinary tract infec-
tion. She had received hormone replacement treatment with estrogen and proges-
terone for 5 yr. A pinpoint ulceration at slightly elevated anterior vaginal wall was
found and biopsy revealed endometrioid adenocarcinoma. Magnetic resonance
imaging showed the 4.3 cm sized mass in urethrovaginal septum. She has under-
gone anterior pelvic exenteration, pelvic lymph node dissection, and urostomy with
ileal conduit. Microscopic finding of the pathology revealed endometrioid adeno-
carcinoma. Co-existence of endometriosis was not identified. Tumor at urethrovagi-
nal septum was difficult to be detected till growing to be bulky, because of vaginal
axis, misunderstanding of the tumor as symphysis pubis, no definitive symptom,
and its rarity. This is the first reported case of extraovarian endometrioid adenocar-
cinoma developed at the urethrovaginal septum. Understanding normal functional
anatomy and meticulous physical examination are essential to detect this rare tumor
in the urethrovaginal septum.
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rectocutaneous fistula. She had no evidence of disease for 24
months.
Pathological examination
Grossly 5×2×1.5 cm sized urethrovaginal mass protrud-
ing into urethra with focal villous appearance was present.
The tumor had formed a fistula tract into the vagina (Fig.
2A) which was replaced by defect of punch biopsy. On serial
section, the cut surface of the tumor was largely necrotic.
The epicenter of the tumor was between urethra and vagi-
na. Microscopically mucosal invasion was noticed in both
vagina and urethra.
Microscopically grade 2 endometrioid adenocarcinoma was
confirmed (Fig. 2B). No histological evidence of endometrio-
sis was identified. The endometrium and the myometrium
were atrophic. The cervix and both adnexae appeared nor-
mal. No lymph node metastasis was seen.
The immnunohistochemical staining was negative for
estrogen receptor (ER), progesterone receptor (PR), CD10,
hMLH 1, and hMSH 2. But bcl-2 was positive in 30% of
tumor cell. And p16 and p53 were positive in 85% and 90%
of tumor nucleus, respectively.
DISCUSSION
Primary vaginal cancer constitutes about 2% of malignant
neoplasm of the female genital tract (2). Eighty four percent
of vaginal cancer was secondary, from the cervix (32%), the
endometrium (18%), the colon and rectum (9%), the ovary
(6%), or the vulva (6%). Most patients with vaginal cancer
experience painless vaginal bleeding and discharge (2). Pri-
mary carcinoma of the female urethra is rare malignancy,
accounting for less than 0.1% of all female genital malig-
nancies (1). Most tumors involve the anterior or the distal
urethra and may be confused with a urethral caruncle or
mucosal prolapse. The most common symptoms include
urethral bleeding, hematuria, dysuria, urinary obstruction,
Fig. 1. T2-weighted sagittal MR image shows an ovoid and solid
mass between urethra and vagina. Note the ill-defined margin of
mass (arrows) with bladder and urethra suggesting invasion.
Fig. 2. Endometrioid adenocarcinoma in the urethrovaginal septum. (A) Posterior surface of gross surgical specimen of anterior pelvic
exenteration. Defect in vaginal wall from previous punch biopsy was seen in the center of the elevated mass. (B) Microscopic finding of
endometrioid adenocarcinoma (H&E, ×40).
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urinary frequency, and a mass at the introitus (2).
Tumors in lower female genital area were relatively rare
but mostly it can be easily detected because of its early appear-
ing symptom when it involves vaginal or urethral mucosa.
But, Nagai et al. (3) reported that even 7 cm sized leiomy-
oma in urethrovaginal septum caused no symptoms except
for urinary retention. Recurrent urinary tract infection was
the only clue to suggest the mass in urethrovaginal septum
for the first time in this case. It is essential to examine anteri-
or vaginal wall in patients with urinary tract symptoms includ-
ing recurrent urinary tract infection, and urinary retention.
We would like to name the urethrovaginal septum as the
‘‘retropubic shadow’’ for gynecologists for the following rea-
sons. Firstly, fingertips of palpating vagina direct to promon-
tory. It is another direction to urethrovaginal septum. Col-
pogram of healthy women revealed that the upper third of
the vagina lays almost horizontally to the coccyx and vaginal
axis formed by levator ani make fingertips entering vaginal
cavity to go to bending toward promontory. This is remark-
able at pelvic examination, because of more acute vaginal
axis with patient’s straining of levator ani (Fig. 3A) (4). Sec-
ondly, the small mass at urethrovaginal septum could be mis-
understood as symphysis pubis (Fig. 3B). Thirdly, the actu-
al primary urethrovaginal carcinoma like in this case is not
accompanied by evident symptoms such as hematuria or
vaginal bleeding until the tumor penetrates the mucosa of
vagina or urethra (5). Lastly, the rarity of this condition makes
it hard for physicians to consider the possibility of this par-
ticular disease (2).
Extraovarian endometrioid adenocarcinoma and adenosar-
coma could be developed from endometriosis with unopposed
estrogen replacement (5-8). However, in this case, the woman
had been received estrogen with progesterone and immuno-
histochemical staining was negative for ER and PR. And
endometriosis as precursor lesion was not identified. So, we
think that the tumor in this patient have different patho-
genesis compared to previously reported cases.
To the best of our knowledge, this is the first reported case
of extraovarian endometrioid adenocarcinoma developed at
urethrovaginal septum. Understanding normal functional
anatomy and meticulous physical examination are essential to
early detection of this rare tumor in urethrovaginal septum.
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